Update from Dr. Lauren Trepanier’s research looking at any genetic and environmental risk for lymphoma in dogs.
Research Update End-Year-1 CHF 02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B cell Lymphoma
Research update and the end of the first year from Dr. Matthew Breen looking at prediction of prognosis and outcome for various forms of lymphoma.
Research Update End-Year 3 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk
End-year 3 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma. Progress continues in the researcher’s efforts into this population of B cell lymphomas similar to the aggressive form seen in humans.
One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma
Update from the first year of work on MAF co-sponsored project D16CA-056, Measuring chemotherapy drug resistance in dogs with T-cell lymphoma; Paul R. Hess, DVM, PhD, North Carolina State University.
Continue reading “One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma”
Research Update End-Year 2 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk
End-year 2 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma. Progress continues in the researcher’s efforts into this population of B cell lymphomas similar to the aggressive form seen in humans.
Update End-Year 3 for Cancer Vaccine Research underway by Nicola Mason
Update for year-end 3 for work being done to optimize a cell-based cancer vaccine approach to improving outcomes in dogs with non-Hodgkins lymphoma.
Continue reading “Update End-Year 3 for Cancer Vaccine Research underway by Nicola Mason”
Update on Cancer Vaccine Research underway by Nicola Mason
Update for year-end 2 for work being done to optimize a cell-based cancer vaccine approach to improving outcomes in dogs with non-Hodgkins lymphoma.
Continue reading “Update on Cancer Vaccine Research underway by Nicola Mason”
Research Update for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk
Mid-year 2 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma.
